Resources Investment Advisors, Llc. Inozyme Pharma, Inc. Transaction History
Resources Investment Advisors, Llc.
- $8.28 Billion
- Q4 2024
A detailed history of Resources Investment Advisors, Llc. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 51,000 shares of INZY stock, worth $49,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,000
Previous 20,000
155.0%
Holding current value
$49,470
Previous $104,000
35.58%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding INZY
# of Institutions
104Shares Held
50.7MCall Options Held
2.6KPut Options Held
5.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA5.16MShares$5.01 Million0.03% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA4.49MShares$4.36 Million11.45% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA4.28MShares$4.15 Million0.97% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.97MShares$3.85 Million1.97% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.86MShares$3.75 Million0.43% of portfolio
About Inozyme Pharma, Inc.
- Ticker INZY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,145,700
- Market Cap $38.9M
- Description
- Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...